We have demonstrated the efficacy of DMFT on CD20 positive (CD20+) Raji B cells in vitro [14,15], in vivo on a disseminated non-Hodgkin lymphoma (NHL) model in SCID mice [16,17], and on patient cells diagnosed with various blood borne malignancies [18]. Here, MS4A1 is linked to non-Hodgkin lymphoma.